rs542973906

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000726.5(CACNB4):​c.8C>T​(p.Ser3Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000292 in 1,535,312 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00023 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00030 ( 2 hom. )

Consequence

CACNB4
NM_000726.5 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:4

Conservation

PhyloP100: 0.931

Publications

2 publications found
Variant links:
Genes affected
CACNB4 (HGNC:1404): (calcium voltage-gated channel auxiliary subunit beta 4) This gene encodes a member of the beta subunit family of voltage-dependent calcium channel complex proteins. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. The protein encoded by this locus plays an important role in calcium channel function by modulating G protein inhibition, increasing peak calcium current, controlling the alpha-1 subunit membrane targeting and shifting the voltage dependence of activation and inactivation. Certain mutations in this gene have been associated with idiopathic generalized epilepsy (IGE), juvenile myoclonic epilepsy (JME), and episodic ataxia, type 5. [provided by RefSeq, Aug 2016]
CACNB4 Gene-Disease associations (from GenCC):
  • episodic ataxia type 5
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, idiopathic generalized, susceptibility to, 9
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000726.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02147293).
BP6
Variant 2-152099004-G-A is Benign according to our data. Variant chr2-152099004-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 204938.
BS2
High AC in GnomAd4 at 35 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000726.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB4
NM_000726.5
MANE Select
c.8C>Tp.Ser3Phe
missense
Exon 1 of 14NP_000717.2O00305-1
CACNB4
NM_001145798.2
c.8C>Tp.Ser3Phe
missense
Exon 1 of 13NP_001139270.1O00305-4
CACNB4
NM_001005746.4
c.-355C>T
upstream_gene
N/ANP_001005746.1O00305-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB4
ENST00000539935.7
TSL:1 MANE Select
c.8C>Tp.Ser3Phe
missense
Exon 1 of 14ENSP00000438949.1O00305-1
CACNB4
ENST00000201943.10
TSL:1
c.8C>Tp.Ser3Phe
missense
Exon 1 of 13ENSP00000201943.5O00305-4
CACNB4
ENST00000427385.6
TSL:5
c.8C>Tp.Ser3Phe
missense
Exon 1 of 13ENSP00000410978.2A0A1C7CYX2

Frequencies

GnomAD3 genomes
AF:
0.000230
AC:
35
AN:
152126
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000269
AC:
37
AN:
137724
AF XY:
0.000229
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000507
Gnomad ASJ exome
AF:
0.000398
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000660
Gnomad NFE exome
AF:
0.000457
Gnomad OTH exome
AF:
0.000263
GnomAD4 exome
AF:
0.000299
AC:
413
AN:
1383066
Hom.:
2
Cov.:
31
AF XY:
0.000290
AC XY:
198
AN XY:
682540
show subpopulations
African (AFR)
AF:
0.0000330
AC:
1
AN:
30294
American (AMR)
AF:
0.0000326
AC:
1
AN:
30646
Ashkenazi Jewish (ASJ)
AF:
0.000413
AC:
10
AN:
24242
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34588
South Asian (SAS)
AF:
0.000402
AC:
31
AN:
77188
European-Finnish (FIN)
AF:
0.000102
AC:
5
AN:
49146
Middle Eastern (MID)
AF:
0.00196
AC:
9
AN:
4602
European-Non Finnish (NFE)
AF:
0.000309
AC:
332
AN:
1075192
Other (OTH)
AF:
0.000420
AC:
24
AN:
57168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
21
41
62
82
103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000230
AC:
35
AN:
152246
Hom.:
1
Cov.:
31
AF XY:
0.000255
AC XY:
19
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41566
American (AMR)
AF:
0.00
AC:
0
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4824
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000382
AC:
26
AN:
67992
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000284
Hom.:
0
Bravo
AF:
0.000170

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
-
1
Episodic ataxia type 5 (1)
-
1
-
Idiopathic generalized epilepsy (1)
-
-
1
Juvenile myoclonic epilepsy (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.070
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.067
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.59
T
MetaRNN
Benign
0.021
T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
-0.34
N
PhyloP100
0.93
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.22
N
REVEL
Benign
0.19
Sift
Benign
0.055
T
Sift4G
Benign
0.12
T
PromoterAI
-0.031
Neutral
Varity_R
0.11
gMVP
0.36
Mutation Taster
=94/6
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs542973906;
hg19: chr2-152955518;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.